A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Haridas Upadya, S. Prabhu, Aravinda Prasad, Deepa Subramanian, Swati Gupta, Ajay Goel

ABSTRACT

BACKGROUND: Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as found in the fresh wild amla fruit) in patients with dyslipidemia. METHODS: A total of 98 dyslipidemic patients were enrolled and divided into amla and placebo groups. Amla extract (500 mg) or a matching placebo capsule was administered twice daily for 12 weeks to the respective group of patients. The patients were followed up for 12 weeks and efficacy of study medication was assessed by analyzing lipid profile. Other parameters evaluated were apolipoprotein B (Apo B), apolipoprotein A1 (Apo A1), Coenzyme Q10 (CoQ10), high-sensitive C-reactive protein (hsCRP), fasting blood sugar (FBS), homocysteine and thyroid stimulating hormone (TSH). RESULTS: In 12 weeks, the major lipids such as total cholesterol (TC) (p = 0.0003), triglyceride (TG) (p = 0.0003), low density lipoprotein cholesterol (LDL-C) (p = 0.0064) and very low density lipoprotein cholesterol (VLDL-C) (p = 0.0001) were significantly lower in amla group as compared to placebo group. Additionally, a 39% reduction in atherogenic index of the plasma (AIP) (p = 0.0177) was also noted in amla group. The ratio of Apo B to Apo A1 was reduced more (p = 0.0866) in the amla group as compared to the placebo. There was no significant change in CoQ10 level of amla (p = 0.2942) or placebo groups (p = 0.6744). Although there was a general trend of FBS reduction, the numbers of participants who may be classified as pre-diabetes and diabetes groups (FBS > 100 mg/dl) in the amla group were only 8. These results show that the amla extract used in the study is potentially a hypoglycaemic as well. However, this needs reconfirmation in a larger study. CONCLUSIONS: The Amla extract has shown significant potential in reducing TC and TG levels as well as lipid ratios, AIP and apoB/apo A-I in dyslipidemic persons and thus has scope to treat general as well as diabetic dyslipidemia. A single agent to reduce cholesterol as well as TG is rare. Cholesterol reduction is achieved without concomitant reduction of Co Q10, in contrast to what is observed with statins. TRIAL REGISTRATION: Registered with Clinical Trials Registry- India at www.ctri.nic.in (Registration number: CTRI/2015/04/005682 ) on 8 April 2015 (retrospectively registered). More... »

PAGES

27

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y

DOI

http://dx.doi.org/10.1186/s12906-019-2430-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111593666

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30670010


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apolipoprotein A-I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apolipoproteins B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dyslipidemias", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypolipidemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phyllanthus emblica", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plant Extracts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triglycerides", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Aadhitya Adhikari Hospital, Contour Road, Gokulam, 570002, Mysore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Upadya", 
        "givenName": "Haridas", 
        "id": "sg:person.01300545725.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300545725.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "LifeCare Hospital, No.99, OM Complex, 20th Main, Gangothri Circle, BTM 1st Stage, 560029, Bangalore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prabhu", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sri Venkateshwara Hospital, No.86, Hosur Main Road, Madiwala, 560068, Bangalore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prasad", 
        "givenName": "Aravinda", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Syncretic Clinical Research Services, No. 4, 5th cross, 11th Main Road, Vasanthnagar, 560052, Bangalore, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Subramanian", 
        "givenName": "Deepa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amrita Institute of Medical Sciences and Research Centre", 
          "id": "https://www.grid.ac/institutes/grid.427788.6", 
          "name": [
            "Amrita School of Pharmacy, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, 682041, Kochi, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gupta", 
        "givenName": "Swati", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411588.1", 
          "name": [
            "Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, 3410 Worth Street, Suite 610, 75246, Dallas, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goel", 
        "givenName": "Ajay", 
        "id": "sg:person.0646110661.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646110661.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0378-8741(01)00361-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000269804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0009-9120(01)00263-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006385801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(01)07098-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007658337"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2010.10.047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007912357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2012.05.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009095252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0253-7613.93857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011677225"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(09)61965-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011777415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00041433-200012000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016545005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00041433-200012000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016545005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehm360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016775888"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1194/jlr.m600233-jlr200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018155894"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(96)00677-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018432805"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.numecd.2009.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018526495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/nyas.12540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019534589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-8741(95)01308-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019765319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0250-474x.27814", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026124607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2006.01644.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027174221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.20.11.2408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027343904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0807646", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029955328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2004.03.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030925161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12291-008-0083-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032016878", 
          "https://doi.org/10.1007/s12291-008-0083-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2006.01649.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033739121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(92)90550-i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035568674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pcd.2014.03.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036366641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lpm.2015.09.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036619188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0250-474x.44604", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037175074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2796.2006.01645.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038882970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehi003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039304662"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.jef.2016.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044112364", 
          "https://doi.org/10.1016/j.jef.2016.02.002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(91)90742-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048418861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1373/clinchem.2004.033175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051062219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)17018-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052249325"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.17.12.3542", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063334594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074645527", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077052779", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077885458", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079538698", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079640587", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081924218", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082268876", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083234232", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/2333794x17694231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083873963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/2333794x17694231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083873963"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as found in the fresh wild amla fruit) in patients with dyslipidemia.\nMETHODS: A total of 98 dyslipidemic patients were enrolled and divided into amla and placebo groups. Amla extract (500\u2009mg) or a matching placebo capsule was administered twice daily for 12\u2009weeks to the respective group of patients. The patients were followed up for 12\u2009weeks and efficacy of study medication was assessed by analyzing lipid profile. Other parameters evaluated were apolipoprotein B (Apo B), apolipoprotein A1 (Apo A1), Coenzyme Q10 (CoQ10), high-sensitive C-reactive protein (hsCRP), fasting blood sugar (FBS), homocysteine and thyroid stimulating hormone (TSH).\nRESULTS: In 12\u2009weeks, the major lipids such as total cholesterol (TC) (p\u2009=\u20090.0003), triglyceride (TG) (p\u2009=\u20090.0003), low density lipoprotein cholesterol (LDL-C) (p\u2009=\u20090.0064) and very low density lipoprotein cholesterol (VLDL-C) (p\u2009=\u20090.0001) were significantly lower in amla group as compared to placebo group. Additionally, a 39% reduction in atherogenic index of the plasma (AIP) (p\u2009=\u20090.0177) was also noted in amla group. The ratio of Apo B to Apo A1 was reduced more (p\u2009=\u20090.0866) in the amla group as compared to the placebo. There was no significant change in CoQ10 level of amla (p\u2009=\u20090.2942) or placebo groups (p\u2009=\u20090.6744). Although there was a general trend of FBS reduction, the numbers of participants who may be classified as pre-diabetes and diabetes groups (FBS\u2009>\u2009100\u2009mg/dl) in the amla group were only 8. These results show that the amla extract used in the study is potentially a hypoglycaemic as well. However, this needs reconfirmation in a larger study.\nCONCLUSIONS: The Amla extract has shown significant potential in reducing TC and TG levels as well as lipid ratios, AIP and apoB/apo A-I in dyslipidemic persons and thus has scope to treat general as well as diabetic dyslipidemia. A single agent to reduce cholesterol as well as TG is rare. Cholesterol reduction is achieved without concomitant reduction of Co Q10, in contrast to what is observed with statins.\nTRIAL REGISTRATION: Registered with Clinical Trials Registry- India at www.ctri.nic.in (Registration number: CTRI/2015/04/005682 ) on 8 April 2015 (retrospectively registered).", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12906-019-2430-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028418", 
        "issn": [
          "1472-6882"
        ], 
        "name": "BMC Complementary and Alternative Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia", 
    "pagination": "27", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5e1af7b177f278dab2a5e510616ae090650be19d5a01f321dd7fbdabca8f516e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30670010"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088661"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12906-019-2430-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111593666"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12906-019-2430-y", 
      "https://app.dimensions.ai/details/publication/pub.1111593666"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000352_0000000352/records_60351_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12906-019-2430-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2430-y'


 

This table displays all metadata directly associated to this object as RDF triples.

283 TRIPLES      21 PREDICATES      84 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12906-019-2430-y schema:about N09723588c3df455592f0a1ad76d409f7
2 N24fc9fe939f84158a3982ad38a242632
3 N3862230d78864a698b1d1a883e964c02
4 N4fed177e5e28426899333432c56827b4
5 N59c74628bf97419bb76f707a95b931c5
6 N5e3f7e4c76384df085f7889021af7159
7 N72548b3cabea4a9583baf7dbd31dfd4d
8 N968a34c6fe104a8c88c59f445c1b8eb0
9 N9afd5ab2d6044e5f89161777cf5d1dcf
10 Na1c7930f5801458db630ffc8d50016d6
11 Na4cb9ecaff3a45b1b6ad0785c148db1d
12 Nbd111c0933254257a54f6abb62d36c86
13 Nd1e5e1ed2e5d4227819074b065b04904
14 Nf086435097d0457c8745b57bca524b8d
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N3745cffa0a77411682888f51e1c6c093
18 schema:citation sg:pub.10.1007/s12291-008-0083-6
19 sg:pub.10.1016/j.jef.2016.02.002
20 https://app.dimensions.ai/details/publication/pub.1074645527
21 https://app.dimensions.ai/details/publication/pub.1077052779
22 https://app.dimensions.ai/details/publication/pub.1077885458
23 https://app.dimensions.ai/details/publication/pub.1079538698
24 https://app.dimensions.ai/details/publication/pub.1079640587
25 https://app.dimensions.ai/details/publication/pub.1081924218
26 https://app.dimensions.ai/details/publication/pub.1082268876
27 https://app.dimensions.ai/details/publication/pub.1083234232
28 https://doi.org/10.1016/0002-9149(91)90742-4
29 https://doi.org/10.1016/0002-9149(92)90550-i
30 https://doi.org/10.1016/0378-8741(95)01308-3
31 https://doi.org/10.1016/j.ahj.2004.03.021
32 https://doi.org/10.1016/j.jacc.2010.10.047
33 https://doi.org/10.1016/j.jacc.2012.05.019
34 https://doi.org/10.1016/j.lpm.2015.09.015
35 https://doi.org/10.1016/j.numecd.2009.11.002
36 https://doi.org/10.1016/j.pcd.2014.03.007
37 https://doi.org/10.1016/s0002-9149(96)00677-7
38 https://doi.org/10.1016/s0009-9120(01)00263-6
39 https://doi.org/10.1016/s0140-6736(01)07098-2
40 https://doi.org/10.1016/s0140-6736(04)17018-9
41 https://doi.org/10.1016/s0140-6736(09)61965-6
42 https://doi.org/10.1016/s0378-8741(01)00361-0
43 https://doi.org/10.1056/nejmoa0807646
44 https://doi.org/10.1093/eurheartj/ehi003
45 https://doi.org/10.1093/eurheartj/ehm360
46 https://doi.org/10.1097/00041433-200012000-00008
47 https://doi.org/10.1111/j.1365-2796.2006.01644.x
48 https://doi.org/10.1111/j.1365-2796.2006.01645.x
49 https://doi.org/10.1111/j.1365-2796.2006.01649.x
50 https://doi.org/10.1111/nyas.12540
51 https://doi.org/10.1161/01.atv.17.12.3542
52 https://doi.org/10.1161/01.atv.20.11.2408
53 https://doi.org/10.1177/2333794x17694231
54 https://doi.org/10.1194/jlr.m600233-jlr200
55 https://doi.org/10.1373/clinchem.2004.033175
56 https://doi.org/10.4103/0250-474x.27814
57 https://doi.org/10.4103/0250-474x.44604
58 https://doi.org/10.4103/0253-7613.93857
59 schema:datePublished 2019-12
60 schema:datePublishedReg 2019-12-01
61 schema:description BACKGROUND: Dyslipidemia is one of the most frequently implicated risk factors for development of atherosclerosis. This study evaluated the efficacy of amla (Emblica officinalis) extract (composed of polyphenols, triterpenoids, oils etc. as found in the fresh wild amla fruit) in patients with dyslipidemia. METHODS: A total of 98 dyslipidemic patients were enrolled and divided into amla and placebo groups. Amla extract (500 mg) or a matching placebo capsule was administered twice daily for 12 weeks to the respective group of patients. The patients were followed up for 12 weeks and efficacy of study medication was assessed by analyzing lipid profile. Other parameters evaluated were apolipoprotein B (Apo B), apolipoprotein A1 (Apo A1), Coenzyme Q10 (CoQ10), high-sensitive C-reactive protein (hsCRP), fasting blood sugar (FBS), homocysteine and thyroid stimulating hormone (TSH). RESULTS: In 12 weeks, the major lipids such as total cholesterol (TC) (p = 0.0003), triglyceride (TG) (p = 0.0003), low density lipoprotein cholesterol (LDL-C) (p = 0.0064) and very low density lipoprotein cholesterol (VLDL-C) (p = 0.0001) were significantly lower in amla group as compared to placebo group. Additionally, a 39% reduction in atherogenic index of the plasma (AIP) (p = 0.0177) was also noted in amla group. The ratio of Apo B to Apo A1 was reduced more (p = 0.0866) in the amla group as compared to the placebo. There was no significant change in CoQ10 level of amla (p = 0.2942) or placebo groups (p = 0.6744). Although there was a general trend of FBS reduction, the numbers of participants who may be classified as pre-diabetes and diabetes groups (FBS > 100 mg/dl) in the amla group were only 8. These results show that the amla extract used in the study is potentially a hypoglycaemic as well. However, this needs reconfirmation in a larger study. CONCLUSIONS: The Amla extract has shown significant potential in reducing TC and TG levels as well as lipid ratios, AIP and apoB/apo A-I in dyslipidemic persons and thus has scope to treat general as well as diabetic dyslipidemia. A single agent to reduce cholesterol as well as TG is rare. Cholesterol reduction is achieved without concomitant reduction of Co Q10, in contrast to what is observed with statins. TRIAL REGISTRATION: Registered with Clinical Trials Registry- India at www.ctri.nic.in (Registration number: CTRI/2015/04/005682 ) on 8 April 2015 (retrospectively registered).
62 schema:genre research_article
63 schema:inLanguage en
64 schema:isAccessibleForFree true
65 schema:isPartOf Na376659fc96b4140974f5ca592e8e194
66 Ndf903d72b0eb4f35b30b14a8b6002517
67 sg:journal.1028418
68 schema:name A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
69 schema:pagination 27
70 schema:productId N09faf051e90142deae0bf280bf5cf3ca
71 N4a4cb2fac90349978e73ce490c74b5e8
72 N7bcda3b20b404c92a4d49569af71a601
73 N973252fdd4f04577ac21c62a036468c0
74 Nbd852c1e4ffe4703a976527965d3a553
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111593666
76 https://doi.org/10.1186/s12906-019-2430-y
77 schema:sdDatePublished 2019-04-11T11:02
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher Nd333a77269b244ddafbdeeefba68a867
80 schema:url https://link.springer.com/10.1186%2Fs12906-019-2430-y
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N09723588c3df455592f0a1ad76d409f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Phyllanthus emblica
86 rdf:type schema:DefinedTerm
87 N09faf051e90142deae0bf280bf5cf3ca schema:name pubmed_id
88 schema:value 30670010
89 rdf:type schema:PropertyValue
90 N1050cdb280124b60a3916912ffd92d15 schema:name Sri Venkateshwara Hospital, No.86, Hosur Main Road, Madiwala, 560068, Bangalore, India
91 rdf:type schema:Organization
92 N24fc9fe939f84158a3982ad38a242632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Hypolipidemic Agents
94 rdf:type schema:DefinedTerm
95 N300b9b425cbb4420b8d70100fa1a2bd9 schema:affiliation https://www.grid.ac/institutes/grid.427788.6
96 schema:familyName Gupta
97 schema:givenName Swati
98 rdf:type schema:Person
99 N3745cffa0a77411682888f51e1c6c093 rdf:first sg:person.01300545725.35
100 rdf:rest N6e0ae809dd864369a4e141390eebe416
101 N3862230d78864a698b1d1a883e964c02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Cholesterol
103 rdf:type schema:DefinedTerm
104 N3dae4f27aea04aeda769022c6fb51191 schema:name Syncretic Clinical Research Services, No. 4, 5th cross, 11th Main Road, Vasanthnagar, 560052, Bangalore, India
105 rdf:type schema:Organization
106 N4a4cb2fac90349978e73ce490c74b5e8 schema:name doi
107 schema:value 10.1186/s12906-019-2430-y
108 rdf:type schema:PropertyValue
109 N4fed177e5e28426899333432c56827b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Middle Aged
111 rdf:type schema:DefinedTerm
112 N51dd7b97832649a39a9c3a4883155396 rdf:first Nf02ebd3c0df94ea894b32170fd8c9f81
113 rdf:rest Nadb12e088b9745fba5838b276c20b151
114 N59c74628bf97419bb76f707a95b931c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Triglycerides
116 rdf:type schema:DefinedTerm
117 N5c0e9426675f4066b8cc141af9034e00 rdf:first N890b24cc2c1248d4af656a8f7b87a5df
118 rdf:rest N51dd7b97832649a39a9c3a4883155396
119 N5e3f7e4c76384df085f7889021af7159 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Apolipoproteins B
121 rdf:type schema:DefinedTerm
122 N6e0ae809dd864369a4e141390eebe416 rdf:first Nf3b6263240464e6084409a1b82459b02
123 rdf:rest N5c0e9426675f4066b8cc141af9034e00
124 N72548b3cabea4a9583baf7dbd31dfd4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 N7bcda3b20b404c92a4d49569af71a601 schema:name readcube_id
128 schema:value 5e1af7b177f278dab2a5e510616ae090650be19d5a01f321dd7fbdabca8f516e
129 rdf:type schema:PropertyValue
130 N890b24cc2c1248d4af656a8f7b87a5df schema:affiliation N1050cdb280124b60a3916912ffd92d15
131 schema:familyName Prasad
132 schema:givenName Aravinda
133 rdf:type schema:Person
134 N968a34c6fe104a8c88c59f445c1b8eb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Adult
136 rdf:type schema:DefinedTerm
137 N973252fdd4f04577ac21c62a036468c0 schema:name dimensions_id
138 schema:value pub.1111593666
139 rdf:type schema:PropertyValue
140 N9afd5ab2d6044e5f89161777cf5d1dcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Plant Extracts
142 rdf:type schema:DefinedTerm
143 Na1c7930f5801458db630ffc8d50016d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Dyslipidemias
145 rdf:type schema:DefinedTerm
146 Na376659fc96b4140974f5ca592e8e194 schema:volumeNumber 19
147 rdf:type schema:PublicationVolume
148 Na4cb9ecaff3a45b1b6ad0785c148db1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Humans
150 rdf:type schema:DefinedTerm
151 Nadb12e088b9745fba5838b276c20b151 rdf:first N300b9b425cbb4420b8d70100fa1a2bd9
152 rdf:rest Nd124e56d2e3047f4ae80933f4ce71056
153 Nbd111c0933254257a54f6abb62d36c86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Apolipoprotein A-I
155 rdf:type schema:DefinedTerm
156 Nbd852c1e4ffe4703a976527965d3a553 schema:name nlm_unique_id
157 schema:value 101088661
158 rdf:type schema:PropertyValue
159 Nbe00d504e5144a23b49dc6f096dcc0db schema:name Aadhitya Adhikari Hospital, Contour Road, Gokulam, 570002, Mysore, India
160 rdf:type schema:Organization
161 Ncfb12ac10f4042bb881f84c139428206 schema:name LifeCare Hospital, No.99, OM Complex, 20th Main, Gangothri Circle, BTM 1st Stage, 560029, Bangalore, India
162 rdf:type schema:Organization
163 Nd124e56d2e3047f4ae80933f4ce71056 rdf:first sg:person.0646110661.20
164 rdf:rest rdf:nil
165 Nd1e5e1ed2e5d4227819074b065b04904 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Female
167 rdf:type schema:DefinedTerm
168 Nd333a77269b244ddafbdeeefba68a867 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 Ndf903d72b0eb4f35b30b14a8b6002517 schema:issueNumber 1
171 rdf:type schema:PublicationIssue
172 Nf02ebd3c0df94ea894b32170fd8c9f81 schema:affiliation N3dae4f27aea04aeda769022c6fb51191
173 schema:familyName Subramanian
174 schema:givenName Deepa
175 rdf:type schema:Person
176 Nf086435097d0457c8745b57bca524b8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Double-Blind Method
178 rdf:type schema:DefinedTerm
179 Nf3b6263240464e6084409a1b82459b02 schema:affiliation Ncfb12ac10f4042bb881f84c139428206
180 schema:familyName Prabhu
181 schema:givenName S.
182 rdf:type schema:Person
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
187 schema:name Clinical Sciences
188 rdf:type schema:DefinedTerm
189 sg:journal.1028418 schema:issn 1472-6882
190 schema:name BMC Complementary and Alternative Medicine
191 rdf:type schema:Periodical
192 sg:person.01300545725.35 schema:affiliation Nbe00d504e5144a23b49dc6f096dcc0db
193 schema:familyName Upadya
194 schema:givenName Haridas
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300545725.35
196 rdf:type schema:Person
197 sg:person.0646110661.20 schema:affiliation https://www.grid.ac/institutes/grid.411588.1
198 schema:familyName Goel
199 schema:givenName Ajay
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646110661.20
201 rdf:type schema:Person
202 sg:pub.10.1007/s12291-008-0083-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032016878
203 https://doi.org/10.1007/s12291-008-0083-6
204 rdf:type schema:CreativeWork
205 sg:pub.10.1016/j.jef.2016.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044112364
206 https://doi.org/10.1016/j.jef.2016.02.002
207 rdf:type schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1074645527 schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1077052779 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1077885458 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1079538698 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1079640587 schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1081924218 schema:CreativeWork
214 https://app.dimensions.ai/details/publication/pub.1082268876 schema:CreativeWork
215 https://app.dimensions.ai/details/publication/pub.1083234232 schema:CreativeWork
216 https://doi.org/10.1016/0002-9149(91)90742-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048418861
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/0002-9149(92)90550-i schema:sameAs https://app.dimensions.ai/details/publication/pub.1035568674
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/0378-8741(95)01308-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019765319
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/j.ahj.2004.03.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030925161
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/j.jacc.2010.10.047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007912357
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/j.jacc.2012.05.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009095252
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.lpm.2015.09.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036619188
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.numecd.2009.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018526495
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.pcd.2014.03.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036366641
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0002-9149(96)00677-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018432805
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s0009-9120(01)00263-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006385801
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s0140-6736(01)07098-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007658337
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/s0140-6736(04)17018-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052249325
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/s0140-6736(09)61965-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011777415
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/s0378-8741(01)00361-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000269804
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1056/nejmoa0807646 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029955328
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1093/eurheartj/ehi003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039304662
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1093/eurheartj/ehm360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016775888
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1097/00041433-200012000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016545005
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1111/j.1365-2796.2006.01644.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027174221
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1111/j.1365-2796.2006.01645.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038882970
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1111/j.1365-2796.2006.01649.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033739121
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1111/nyas.12540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019534589
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1161/01.atv.17.12.3542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063334594
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1161/01.atv.20.11.2408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027343904
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1177/2333794x17694231 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083873963
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1194/jlr.m600233-jlr200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018155894
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1373/clinchem.2004.033175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051062219
271 rdf:type schema:CreativeWork
272 https://doi.org/10.4103/0250-474x.27814 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026124607
273 rdf:type schema:CreativeWork
274 https://doi.org/10.4103/0250-474x.44604 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037175074
275 rdf:type schema:CreativeWork
276 https://doi.org/10.4103/0253-7613.93857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011677225
277 rdf:type schema:CreativeWork
278 https://www.grid.ac/institutes/grid.411588.1 schema:alternateName Baylor University Medical Center
279 schema:name Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, 3410 Worth Street, Suite 610, 75246, Dallas, TX, USA
280 rdf:type schema:Organization
281 https://www.grid.ac/institutes/grid.427788.6 schema:alternateName Amrita Institute of Medical Sciences and Research Centre
282 schema:name Amrita School of Pharmacy, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, 682041, Kochi, India
283 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...